Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 60,500 KRW
Change Today +2,700 / 4.67%
Volume 219.3K
049960 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 12:59 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for cell biotech co ltd (049960)

Year over year, Cell Biotech Co. Ltd. has been able to grow revenues from 31.6B KRW to 40.8B KRW. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 30.96% to 27.63%. This was a driver that led to a bottom line growth from 7.8B KRW to 10.4B KRW.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2011
KRW
Dec 31
2012
KRW
Dec 31
2013
KRW
Dec 31
2014
KRW
4 Year
Trend
Revenues23,318.125,889.231,597.840,767.7
Other Revenues--0.0----
TOTAL REVENUES23,318.125,889.231,597.840,767.7
Cost of Goods Sold8,443.48,769.09,783.411,265.2
GROSS PROFIT14,874.717,120.221,814.429,502.5
Selling General & Admin Expenses, Total7,227.58,680.610,233.414,076.4
R&D Expenses1,533.41,615.31,916.32,056.6
Depreciation & Amortization, Total199.4188.8185.7357.0
Other Operating Expenses82.8100.787.4106.9
OTHER OPERATING EXPENSES, TOTAL9,043.110,585.312,422.916,597.0
OPERATING INCOME5,831.56,534.99,391.612,905.5
Interest Expense-5.3-9.7-2.1--
Interest and Investment Income451.2526.8400.8493.5
NET INTEREST EXPENSE445.8517.1398.7493.5
Currency Exchange Gains (Loss)-80.8-190.9117.4-373.7
Other Non-Operating Income (Expenses)-30.6290.0-1.072.2
EBT, EXCLUDING UNUSUAL ITEMS6,166.07,151.19,906.613,097.5
Gain (Loss) on Sale of Investments47.818.489.48.9
Gain (Loss) on Sale of Assets22.745.2-10.3-27.6
Other Unusual Items, Total-----273.8--
EBT, INCLUDING UNUSUAL ITEMS6,236.47,214.79,711.913,078.7
Income Tax Expense1,019.71,089.81,912.12,676.0
Minority Interest in Earnings-14.115.8----
Earnings from Continuing Operations5,216.76,124.97,799.810,402.7
NET INCOME5,202.76,140.77,799.810,402.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS5,202.76,140.77,799.810,402.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS5,202.76,140.77,799.810,402.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
049960:KS 60,500.00 KRW +2,700

049960 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 049960.
View Industry Companies
 

Industry Analysis

049960

Industry Average

Valuation 049960 Industry Range
Price/Earnings 43.6x
Price/Sales 11.1x
Price/Book 8.7x
Price/Cash Flow 51.3x
TEV/Sales 12.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELL BIOTECH CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.